I have 20 years of experience in trading. I also have a extensive experience with drug development. I combine technical analysis, valuation of the company and the upcoming short term catalysts before trading. I will set a target price and very tight stop loss limits. I am an active trader and usually sell and jump in again in the same stock until it hits the target price. I like to take my profit after the little runs that the stocks have. It is a more conservative and profitable approach.
Learn More...
132
Total Recommendations
-2
Open Recommendations
26.12 %
Success Rate
1
Total Services
My Services
| Service Name | Avg % Return since Inception | Recommendations Open/Closed | % Success | YTD Return | All Time Return | Risk | Fees | |
|---|---|---|---|---|---|---|---|---|
| Biotechnology | -1.01 % | -2/134 | 26.12 % | -6.11 % | -13.66 % | -5.29 | Free | Follow |
Closed Recommendations
| Symbol | Service | Type | Strategy | Created | Closed | % Return |
|---|---|---|---|---|---|---|
| AIMT | Biotechnology | Equity | Buy Long | 03/23/18 | 04/03/18 | -5.04 % |
| IDRA | Biotechnology | Equity | Buy Long | 01/26/18 | 04/02/18 | -9.57 % |
| ADMS | Biotechnology | Equity | Buy Long | 03/23/18 | 04/02/18 | -6.31 % |
| AVDL | Biotechnology | Equity | Buy Long | 03/23/18 | 03/27/18 | -4.26 % |
| PRTK | Biotechnology | Equity | Buy Long | 03/23/18 | 03/27/18 | -3.70 % |
| CDTX | Biotechnology | Equity | Buy Long | 03/23/18 | 03/26/18 | -9.09 % |
| CPRX | Biotechnology | Equity | Buy Long | 03/23/18 | 03/23/18 | -2.26 % |
| AKAO | Biotechnology | Equity | Buy Long | 01/02/18 | 03/23/18 | 19.40 % |
| ADXS | Biotechnology | Equity | Buy Long | 03/05/18 | 03/12/18 | 10.61 % |
| SGYP | Biotechnology | Equity | Buy Long | 12/13/17 | 03/05/18 | 11.11 % |
| LXRX | Biotechnology | Equity | Buy Long | 12/21/17 | 02/09/18 | -13.29 % |
| NLNK | Biotechnology | Equity | Buy Long | 01/12/18 | 02/06/18 | -6.54 % |
| PRTK | Biotechnology | Equity | Buy Long | 01/26/18 | 02/02/18 | -4.15 % |
| TTPH | Biotechnology | Equity | Buy Long | 01/11/18 | 02/01/18 | -15.38 % |
| QTNT | Biotechnology | Equity | Buy Long | 01/26/18 | 01/31/18 | -8.26 % |
| ADMP | Biotechnology | Equity | Buy Long | 12/21/17 | 01/29/18 | -14.61 % |
| ACRX | Biotechnology | Equity | Buy Long | 12/13/17 | 01/26/18 | 0.00 % |
| RNN | Biotechnology | Equity | Buy Long | 10/25/17 | 01/26/18 | 22.53 % |
| SCYX | Biotechnology | Equity | Buy Long | 01/12/18 | 01/16/18 | -2.63 % |
| KDMN | Biotechnology | Equity | Buy Long | 12/13/17 | 01/12/18 | 8.38 % |
| TLGT | Biotechnology | Equity | Buy Long | 01/11/18 | 01/12/18 | -4.95 % |
| TGTX | Biotechnology | Equity | Buy Long | 12/07/17 | 01/11/18 | 25.45 % |
| ARDM | Biotechnology | Equity | Buy Long | 01/04/18 | 01/09/18 | -21.88 % |
| OVAS | Biotechnology | Equity | Buy Long | 12/22/17 | 01/04/18 | -7.59 % |
| EYEG | Biotechnology | Equity | Buy Long | 12/13/17 | 01/03/18 | -9.92 % |
| ICPT | Biotechnology | Equity | Buy Long | 12/22/17 | 01/02/18 | -7.58 % |
| AKTX | Biotechnology | Equity | Buy Long | 10/25/17 | 12/22/17 | 4.05 % |
| RXII | Biotechnology | Equity | Buy Long | 11/30/17 | 12/21/17 | -15.91 % |
| KALA | Biotechnology | Equity | Buy Long | 11/10/17 | 12/13/17 | -7.81 % |
| EVOK | Biotechnology | Equity | Buy Long | 11/14/17 | 12/13/17 | -10.39 % |
| ACRX | Biotechnology | Equity | Buy Long | 12/07/17 | 12/12/17 | -9.09 % |
| LXRX | Biotechnology | Equity | Buy Long | 11/30/17 | 12/12/17 | -4.11 % |
| OVAS | Biotechnology | Equity | Buy Long | 11/30/17 | 12/12/17 | -9.40 % |
| SGYP | Biotechnology | Equity | Buy Long | 11/15/17 | 12/07/17 | -3.19 % |
| KDMN | Biotechnology | Equity | Buy Long | 11/03/17 | 12/07/17 | -4.23 % |
| CNAT | Biotechnology | Equity | Buy Long | 11/30/17 | 12/06/17 | -6.92 % |
| ARLZ | Biotechnology | Equity | Buy Long | 11/21/17 | 11/30/17 | -3.27 % |
| ICPT | Biotechnology | Equity | Buy Long | 11/21/17 | 11/28/17 | -3.77 % |
| TSRO | Biotechnology | Equity | Buy Long | 11/15/17 | 11/28/17 | -7.85 % |
| ZIOP | Biotechnology | Equity | Buy Long | 11/14/17 | 11/21/17 | 0.71 % |
| PTCT | Biotechnology | Options | Buy Puts | 10/12/17 | 11/17/17 | -96.43 % |
| PTCT | Biotechnology | Options | Buy Puts | 10/02/17 | 11/17/17 | -96.15 % |
| ADMP | Biotechnology | Equity | Buy Long | 10/18/17 | 11/15/17 | -10.00 % |
| ARDX | Biotechnology | Equity | Buy Long | 11/03/17 | 11/14/17 | -8.62 % |
| TSRO | Biotechnology | Equity | Buy Long | 11/14/17 | 11/14/17 | -1.54 % |
| IOVA | Biotechnology | Equity | Buy Long | 10/25/17 | 11/14/17 | 9.79 % |
| RDHL | Biotechnology | Equity | Buy Long | 11/10/17 | 11/14/17 | -4.49 % |
| TCON | Biotechnology | Equity | Buy Long | 11/03/17 | 11/13/17 | -6.78 % |
| AKAO | Biotechnology | Equity | Buy Long | 11/08/17 | 11/13/17 | -3.97 % |
| KERX | Biotechnology | Equity | Buy Long | 11/08/17 | 11/10/17 | -4.59 % |
| ZIOP | Biotechnology | Equity | Buy Long | 11/08/17 | 11/10/17 | -5.06 % |
| ATNM | Biotechnology | Equity | Buy Long | 10/11/17 | 11/08/17 | -16.38 % |
| ICPT | Biotechnology | Equity | Buy Long | 09/29/17 | 11/08/17 | 8.26 % |
| NVTA | Biotechnology | Equity | Buy Long | 11/03/17 | 11/07/17 | -3.73 % |
| TGTX | Biotechnology | Equity | Buy Long | 10/19/17 | 11/03/17 | 3.90 % |
| MNOV | Biotechnology | Equity | Buy Long | 10/10/17 | 10/27/17 | 7.61 % |
| KERX | Biotechnology | Equity | Buy Long | 10/26/17 | 10/27/17 | -3.00 % |
| ARDX | Biotechnology | Equity | Buy Long | 10/18/17 | 10/26/17 | -11.50 % |
| TSRO | Biotechnology | Equity | Buy Long | 10/25/17 | 10/26/17 | -0.35 % |
| AKAO | Biotechnology | Equity | Buy Long | 10/11/17 | 10/25/17 | -4.90 % |
| TSRO | Biotechnology | Equity | Buy Long | 10/19/17 | 10/25/17 | -3.66 % |
| RNN | Biotechnology | Equity | Buy Long | 10/13/17 | 10/25/17 | -13.88 % |
| LXRX | Biotechnology | Equity | Buy Long | 10/17/17 | 10/24/17 | -4.34 % |
| ACRS | Biotechnology | Equity | Buy Long | 10/17/17 | 10/23/17 | -1.75 % |
| TGTX | Biotechnology | Equity | Buy Long | 10/18/17 | 10/18/17 | -3.66 % |
| SGYP | Biotechnology | Equity | Buy Long | 10/17/17 | 10/18/17 | -5.19 % |
| TSRO | Biotechnology | Equity | Buy Long | 10/12/17 | 10/18/17 | -1.21 % |
| TCON | Biotechnology | Equity | Buy Long | 10/03/17 | 10/17/17 | -13.04 % |
| QTNT | Biotechnology | Equity | Buy Long | 10/02/17 | 10/17/17 | -6.86 % |
| ALDX | Biotechnology | Equity | Buy Long | 10/04/17 | 10/16/17 | -7.38 % |
| ANTH | Biotechnology | Equity | Buy Long | 10/12/17 | 10/16/17 | -6.98 % |
| IMDZ | Biotechnology | Equity | Buy Long | 10/12/17 | 10/16/17 | -2.73 % |
| AXSM | Biotechnology | Equity | Buy Long | 10/02/17 | 10/13/17 | -7.08 % |
| ARDX | Biotechnology | Equity | Buy Long | 09/19/17 | 10/12/17 | 38.39 % |
| GBT | Biotechnology | Equity | Buy Long | 10/04/17 | 10/12/17 | 5.65 % |
| ACRX | Biotechnology | Equity | Buy Long | 08/05/17 | 10/12/17 | -13.79 % |
| AERI | Biotechnology | Equity | Buy Long | 10/02/17 | 10/11/17 | 20.97 % |
| TRVN | Biotechnology | Equity | Buy Long | 10/02/17 | 10/10/17 | -6.84 % |
| AXON | Biotechnology | Equity | Buy Long | 10/03/17 | 10/10/17 | -11.10 % |
| MTFB | Biotechnology | Equity | Buy Long | 09/19/17 | 10/04/17 | 33.49 % |
| HRTX | Biotechnology | Equity | Buy Long | 09/13/17 | 10/03/17 | 14.24 % |
| FLXN | Biotechnology | Equity | Buy Long | 09/29/17 | 10/03/17 | 9.74 % |
| NUVA | Biotechnology | Equity | Buy Long | 09/25/17 | 10/02/17 | 0.11 % |
| ANTH | Biotechnology | Equity | Buy Long | 09/29/17 | 09/29/17 | -4.11 % |
| ZGNX | Biotechnology | Equity | Buy Long | 09/05/17 | 09/29/17 | 134.40 % |
| RDHL | Biotechnology | Equity | Buy Long | 09/11/17 | 09/28/17 | 21.36 % |
| CATB | Biotechnology | Equity | Buy Long | 09/08/17 | 09/28/17 | 37.93 % |
| ICPT | Biotechnology | Equity | Buy Long | 09/26/17 | 09/27/17 | -2.03 % |
| ICPT | Biotechnology | Equity | Buy Long | 09/22/17 | 09/26/17 | -8.90 % |
| FLXN | Biotechnology | Equity | Buy Long | 09/08/17 | 09/25/17 | 7.63 % |
| TRVN | Biotechnology | Equity | Buy Long | 09/20/17 | 09/22/17 | -2.81 % |
| NBRV | Biotechnology | Equity | Buy Long | 09/20/17 | 09/22/17 | -2.28 % |
| VSAR | Biotechnology | Equity | Buy Long | 09/14/17 | 09/20/17 | 21.88 % |
| IDRA | Biotechnology | Equity | Buy Long | 09/05/17 | 09/19/17 | 22.58 % |
| ACRS | Biotechnology | Equity | Buy Long | 09/11/17 | 09/18/17 | -4.92 % |
| RXDX | Biotechnology | Equity | Buy Long | 09/13/17 | 09/18/17 | 15.38 % |
| NBRV | Biotechnology | Equity | Buy Long | 09/13/17 | 09/15/17 | -7.06 % |
| VSAR | Biotechnology | Equity | Buy Long | 09/13/17 | 09/14/17 | -4.76 % |
| TGTX | Biotechnology | Equity | Buy Long | 09/07/17 | 09/12/17 | -4.88 % |
| VSAR | Biotechnology | Equity | Buy Long | 09/08/17 | 09/12/17 | -5.18 % |
| HZNP | Biotechnology | Equity | Buy Long | 08/14/17 | 09/11/17 | 13.91 % |
| ADMP | Biotechnology | Equity | Buy Long | 09/08/17 | 09/11/17 | -2.75 % |
| RDHL | Biotechnology | Equity | Buy Long | 09/08/17 | 09/11/17 | -3.42 % |
| PETX | Biotechnology | Equity | Buy Long | 08/30/17 | 09/08/17 | 11.54 % |
| AUPH | Biotechnology | Equity | Buy Long | 09/06/17 | 09/08/17 | 8.99 % |
| PCRX | Biotechnology | Equity | Buy Long | 08/30/17 | 09/07/17 | 0.41 % |
| AXSM | Biotechnology | Equity | Buy Long | 08/30/17 | 09/07/17 | -9.00 % |
| AXSM | Biotechnology | Equity | Buy Long | 08/30/17 | 09/07/17 | -9.00 % |
| AXSM | Biotechnology | Equity | Buy Long | 08/30/17 | 09/07/17 | -9.00 % |
| NVTA | Biotechnology | Equity | Buy Long | 08/28/17 | 09/06/17 | -2.44 % |
| AUPH | Biotechnology | Equity | Buy Long | 09/01/17 | 09/05/17 | -2.48 % |
| LXRX | Biotechnology | Equity | Buy Long | 08/31/17 | 09/05/17 | -2.32 % |
| FGEN | Biotechnology | Equity | Buy Long | 08/23/17 | 08/31/17 | 13.99 % |
| INSM | Biotechnology | Equity | Buy Long | 08/17/17 | 08/30/17 | 2.73 % |
| INSM | Biotechnology | Equity | Buy Long | 08/24/17 | 08/30/17 | -2.28 % |
| PGNX | Biotechnology | Equity | Buy Long | 08/10/17 | 08/30/17 | 22.80 % |
| KMDA | Biotechnology | Equity | Buy Long | 08/16/17 | 08/30/17 | 2.41 % |
| NVTA | Biotechnology | Equity | Buy Long | 08/22/17 | 08/24/17 | 6.05 % |
| PCRX | Biotechnology | Equity | Buy Long | 08/22/17 | 08/23/17 | -3.45 % |
| PCRX | Biotechnology | Equity | Buy Long | 08/14/17 | 08/21/17 | -3.66 % |
| OMER | Biotechnology | Equity | Buy Long | 08/16/17 | 08/21/17 | -5.60 % |
| ADMP | Biotechnology | Equity | Buy Long | 08/05/17 | 08/17/17 | 0.00 % |
| KMDA | Biotechnology | Equity | Buy Long | 08/14/17 | 08/15/17 | -5.49 % |
| AXSM | Biotechnology | Equity | Buy Long | 08/05/17 | 08/14/17 | -14.05 % |
| PCRX | Biotechnology | Equity | Buy Long | 08/10/17 | 08/11/17 | -2.59 % |
| VSTM | Biotechnology | Equity | Buy Long | 08/09/17 | 08/10/17 | -7.04 % |
| ARLZ | Biotechnology | Equity | Buy Long | 08/05/17 | 08/10/17 | -5.17 % |
| LXRX | Biotechnology | Equity | Buy Long | 08/09/17 | 08/10/17 | -2.88 % |
| SRPT | Biotechnology | Equity | Buy Long | 08/05/17 | 08/10/17 | -3.34 % |
| ABIO | Biotechnology | Equity | Buy Long | 08/09/17 | 08/10/17 | -11.11 % |
| PGNX | Biotechnology | Equity | Buy Long | 08/05/17 | 08/09/17 | -7.09 % |
| ADMP | Biotechnology | Equity | Buy Long | 08/07/17 | 08/09/17 | -5.32 % |
| ABIO | Biotechnology | Equity | Buy Long | 08/05/17 | 08/09/17 | -12.82 % |
| LXRX | Biotechnology | Equity | Buy Long | 08/05/17 | 08/07/17 | -2.72 % |
TRENDING ARTICLES
Canada Stocks Close Down More Than 30 Pts As Market Watchers Says Investors Are Putting Their Money In Cash Instead; Aphria and AltaGas In The News
12/13/18Canada s main stock market the Toronto Stock Exchange on Thursday closed down 32 7 points at 14 750 35 above a day low 14 721 30 touched inside the last hour of trading but 120 points off an early day high as a plethora of issues cast a shadow over markets including uncertainty about
Visa & Mastercard: Strong Growth and Dividend Hike Opportunities?
12/13/18Popular free stock trading app Robinhood announced today that it is launching checking and savings accounts These accounts will not only feature the fee free zero minimum standards that Robinhood users have come to expect but also 3 interest rates on deposits That return is roughly 30
What Investors Should Expect In 2019
12/13/18With our current political climate the EU punishing Britain for Brexit tariffs trade wars the Fed raising rates record government deficits and whatever hysteria the media can create the crystal ball is full of clutter How should investors approach 2019 We
NVIDIA Should Pay a Bigger Dividend -- Here's Why
12/13/18Graphics specialist NVIDIA NASDAQ NVDA first began paying a quarterly dividend back in November 2012 more than six years ago That initial dividend was just 0 075 per share but over time it has grown to 0 16 more than double where it started Although NVIDIA has done
Why Delta Stock Lost 5% Today
12/13/18What happened Shares of Delta Air Lines NYSE DAL 160 were down 5 as of 2 40 p m EST on Thursday as investors reacted to an earnings warning 160 announced at Delta s investor day in New York In a press release preceding the actual conference Delta revealed that
Tesla Stock: Headed to $465?
12/13/18Baird analyst Ben Kallo was already bullish on Tesla NASDAQ TSLA He had an outperform rating on the stock and a 411 price target But now he s even more optimistic reiterating his outperform rating and initiating a new higher 12 month price target To back up his bullish
SeaWorld Shareholders Can Exhale as the Stock Soars Higher
12/13/18One of this year s biggest surprise winners is SeaWorld Entertainment NYSE SEAS Shares of the theme park operator have more than doubled in 2018 up 104 through Wednesday s close The good news keeps coming for the once out of favor entertainer as the Justice Department has
Express Scripts Announces 3-Year Agreement With Walmart
12/13/18Leading pharmacy benefit manager Express Scripts Holding Company ESRX and retail giant 160 Walmart Inc WMT recently announced a three year agreement to deliver affordable prescription solutions to underinsured and uninsured Americans Financial terms of the deal have been kept under
Better Buy: Align Technology vs. Abiomed
12/13/18Align Technology NASDAQ ALGN and Abiomed NASDAQ ABMD 160 have a lot of traits in common They are both medical device companies that dominate their respective niches They have each reached profitability and have been grand slam investments so far While both still
How Do You Monetize a Streaming Platform?
12/13/18The cord cutting revolution kicked off in earnest when Netflix 160 announced its streaming service back in 2007 But another product announcement that year was similarly important Roku s NASDAQ ROKU 160 first Netflix player The device a box that could be connected
Apple Details Domestic Expansion Plans
12/13/18Apple NASDAQ AAPL kicked off 2018 with a massive promise to invest 160 350 billion in the U S over the next five years However that headline figure was a little misleading as it included things like a mandatory 38 billion repatriation tax payment related to its
General Dynamics Wins $25M Deal to Support Submarine Platform
12/13/18General Dynamics Corp s GD Electric Boat division recently secured a 24 8 million modification contract for providing engineering and technical design support services related to the undersea technology for current and future submarine platforms The deal has been awarded by The Naval
Nordson Corporation (NDSN) Q4 2018 Earnings Conference Call Transcript
12/13/18Image source The Motley Fool Nordson Corporation NASDAQ NDSN Q4 2018 Earnings Conference Call Dec 13 2018 8 30 p m ET Contents Prepared Remarks Questions and Answers Call Participants Prepared Remarks Operator
Red Hat (RHT) Set to Report Q3 Earnings: What's in Store?
12/13/18Red Hat Inc RHT is set to report third quarter fiscal 2019 results on Dec 17 We note that on average the company has delivered a positive earnings surprise of 7 2 in the trailing four quarters In the last reported quarter Red Hat delivered positive earnings surprise of 4
Ciena Corporation (CIEN) Q4 2018 Earnings Conference Call Transcript
12/13/18Image source The Motley Fool Ciena Corporation NYSE CIEN Q4 2018 Earnings Conference Call Dec 13 2018 8 30 a m ET Contents Prepared Remarks Questions and Answers Call Participants Prepared Remarks Operator